Brands - All Brands

Founded in 1987 by Kenneth Mann, Ph.D., a prominent scientist in the fields of thrombosis and hemostasis, Prolytix (formerly Haematologic Technologies) quickly developed a reputation as a go-to research reagents company. With expertise in coagulation and hemostasis, we continue to provide highly purified plasma proteins and antibodies to research labs around the world.

Recognizing our extensive protein chemistry expertise, biotech companies, pharmaceutical companies, and CROs turned to Haematologic Technologies for method validation and other analytical and bioanalytical services. The company expanded organically, adding GMP/GCLP CLIA-certified facilities in 2011. In 2020, the company added a high-resolution mass spectrometry (HRMS) lab.

We remain a premier solution for integrated large molecule analytical and bioanalytical services, method and process development, and research reagents, custom tubes, and other collection devices. In early 2022, we became Prolytix to reflect our wide expertise in protein chemistry and analytical services.

Catalog

ProSpec-Tany TechnoGene Ltd is an Israeli Biotechnology company that has over 13 years of experience specializing in production of E.coli-derived recombinant human cytokines and growth factors, as well as Chemokines, Hormones and Viral Antigens. Lately a wide range of monoclonal and polyclonal antibodies has been added to the list.

ProSpec-Tany TechnoGene Ltd. has the technology and experience in bulk production (from microgram to gram quantities) of E.coli-derived recombinant human cytokines, growth factors, monoclonal anti-cytokine and chemokine antibodies. The company's proprietary protein purification technologies developed over the years gave them an edge over the competition resulting from low production costs, high yield and production efficiency.

Its reputation for quality is an essential factor in achieving a favorable position in the market place and the benefits associated with manufacturing top quality products. Every batch is strictly tested to meet the tough requirements of clinical grade Bio-Pharmaceuticals.

Ranomics is committed to enabling transformative discoveries with genomics. Their R&D team has broad expertise in synthetic & molecular biology including: large scale DNA mutagenesis, DNA synthesis, high throughput cell based assays and bioinformatics.  

The wide breadth of technologies combine into a comprehensive, end-to-end functional genomics platform that conducts variant characterization at scale, enabling partners to bring therapies, diagnostics and products to market faster and with lower risk.

Their VariantFind™ technology platform creates highly diverse and scalable DNA variant libraries. It uses a series of multiplex PCRs that effectively mutates multiple amino acid positions simultaneously. Desired mutations are directly encoded by oligonucleotides, providing high control and specificity during the mutagenesis process. VariantFind™ DNA variant libraries are an enabling tool in protein engineering, antibody optimization, synthetic biology and much more.

Since the company was founded in 1991, ScyTek has continued to grow at a rapid rate as a result of commitment to continuous improvement of each and every product line.

In addition, aggressive pricing through vigilant cost containment and continuous improvements in efficiency combined with commitment to quality have helped to foster strong customer bonds.